期刊文献+

PEG-SS(O)-SN38的制备及其自组装胶束的质量评价及初步药效研究 被引量:1

Preparation of PEG-SS(O)-SN38 and Quality Evaluation and Preliminary Pharmacodynamics of Its Self-assembled Micelles
原文传递
导出
摘要 通过二硫键键合聚乙二醇(PEG;)和伊立替康活性代谢物SN38得到还原响应性的两亲性聚合物PEG-SS(O)-SN38,采用薄膜分散法将PEG-SS(O)-SN38制成自组装胶束。透射电镜(TEM)观察显示胶束呈球形或类球形。采用动态光散射法(DLS)测得其平均粒径为(106.3±0.5)nm、多分散系数为0.19±0.05。荧光法测得的临界胶束浓度为(0.070±0.008)mg/ml,提示形成的胶束能较好地维持结构完整性。在体外模拟的还原性环境中,测得该胶束2 h时释出的SN38含量增加至(66.55±0.53)%。在pH 7.4磷酸盐缓冲液(PBS)和胎牛血清(FBS)中,该胶束的48 h累积释放率分别为(50.24±4.53)%、(57.43±2.92)%,说明具有一定的缓释效果;并且,该胶束与PBS孵育24 h或与FBS孵育8 h,粒径几乎不变,表明PEG-SS(O)-SN38形成的胶束在模拟的生理条件下稳定性良好。体外细胞毒性试验结果显示,该胶束对人胰腺癌(Capan-1)细胞具有显著的生长抑制作用。裸小鼠体内药效试验结果显示,与相同剂量的盐酸伊立替康注射液相比,PEG-SS(O)-SN38自组装胶束对荷Capan-1瘤裸小鼠具有明显的肿瘤抑制作用,且裸小鼠体质量没有显著下降。 Reduction-responsive amphiphilic polymer PEG-SS(O)-SN38 was synthesized by conjugation of polyethylene glycol(PEG;) and the active metabolite SN-38 of irinotecan by disulphide bonds.Then,the self-assembled micelles were prepared by thin-film dispersion method.The transmission electron microscopy(TEM) observation revealed that the micelles were spherical in shape.The average particle size and polydispersion index measured by dynamic light scattering were (106.3±0.5)nm and 0.19±0.05.The critical micelle concentration(CMC) measured by fluorescence method was (0.070±0.008)mg/ml,suggesting that the formed micelles could maintain structural integrity.The content of SN38 released from the micelles increased to (66.55±0.53)% after incubation for 2 h in the simulated reductive tumor microenvironment in vitro.The cumulative release amounts at 48 h of the self-assembled micelles were (50.24±4.53)% in pH 7.4 phosphate buffer(PBS) and (57.43±2.92)% in fetal bovine serum(FBS),which proved that the self-assembled PEG-SS(O)-SN38 micelles had sustained-release effects.In addition,the particle sizes of the self-assembled PEG-SS(O)-SN38 micelles were almost unchanged in PBS for 24 h and in FBS for 8 h.The results showed that the self-assembled PEG-SS(O)-SN38 micelles had good stability in a simulated physiological environment.In vitro cytotoxicity showed that the self-assembled PEG-SS(O)-SN38 micelles had a significant growth inhibition effect on human pancreatic cancer(Capan-1) cells.Furthermore,compared with irinotecan hydrochloride injection at the same dose,the self-assembled PEG-SS(O)-SN38 micelles exhibited significant tumor inhibition in the Capan-1 tumor-bearing nude mice without a remarkable decrease in body weight.
作者 贾李瑛 陈伶俐 孙考祥 JIA Liying;CHEN Lingli;SUN Kaoxiang(School of Pharmaceutical Sciences,Yantai University,Yantai 264000;Pharmaceutical Preparation Research Center,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2022年第1期69-76,共8页 Chinese Journal of Pharmaceuticals
关键词 SN38 伊立替康 聚乙二醇化 自组装胶束 还原响应性 稳定性 抗肿瘤 细胞毒性 药效学 SN38 irinotecan PEGylation self-assembled micelle reduction responsiveness stability anti-tumor cytotoxicity pharmacodynamics
  • 相关文献

参考文献9

二级参考文献60

  • 1林宏英,陆晓燕,唐宁,梁伟.长春新碱PEG-PE胶束的制备及其对乳腺癌细胞生长的抑制[J].生物化学与生物物理进展,2006,33(8):769-774. 被引量:14
  • 2杨卓理,杨可伟,李馨儒,刘艳.两性霉素B的聚乙二醇-聚乳酸胶束的制备及其体外释放动力学[J].中国药学杂志,2007,42(7):519-523. 被引量:16
  • 3Ulukan H, Swaan PW. Camptothecins: a review of their chemotherapeutic potential[J]. Drugs, 2002,62(14) : 2 039. 被引量:1
  • 4Garcia-Carbonero R, Supko JG. Current perspectives on the clinical experience, pharmacology, and continued devel- opment of the camptothecins[J]. Clin Cancer Res, 2002,8 (3):641. 被引量:1
  • 5Pommier Y. DNA topoisomerase I inhibitors: chemistry, biology and interracial inhibition[J]. Chem Rev, 2009, 109 (7) :2 894. 被引量:1
  • 6Thakur R, Sivakumar B, Savva M. Thermodynamic stud- ies and loading of 7-ethyl-10-hydroxycamptothecin into mesoporous silica particles MCM-41 in strongly acidic so- lutions[J]. J Phys Chem B, 2010,114 (17) : 5 903. 被引量:1
  • 7Roger E, Lagarce F, Benoit JP. Development and charac- terization of a novel lipid nanocapsule formulation of SN38 for oral administration[J]. European Journal of Ph- armaceutics & Biopharmaceutics , 2011,79 ( 1 ) : 181. 被引量:1
  • 8Koizumi F, Kitagawa M, Negishi T, et al. Novel SN-38-in- corporating polymeric micelles, NK012, eradicate vascu- lar endothelial growth factor-secreting bulky tumors[J]. Cancer Res, 2006,66(20) : 10 048. 被引量:1
  • 9Innocenti F, Kroetz DL, Schuetz E, et al. Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics[J]. Y Clin Oncol, 2009,27 ( 16 ) : 2 604. 被引量:1
  • 10Takakura A, Kurita A, Asahara T, et al. Rapid deconjuga- tion of SN-38 glucuronide and adsorption of released free SN-38 by intestinal microorganisms in rat[J]. Oncol Lett, 2012,3(3) : 520. 被引量:1

共引文献34

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部